Introduction. With age, sex hormone deficiency leads to reduced bone mineral density (BMD) 
Scopul cercetării noastre este de a analiza rolul sexsteroizilor serici în evaluarea DMO la bărbații incluși în studiu. Material și metode. Acest studiu retrospectiv transversal a inclus 146 bărbați cu vârsta cuprinsă între 55-85 ani diagnosticați cu osteoporoză sau osteopenie (grupul studiu) și 121 bărbați cu DMO normală (grupul control
)
Introduction
Sex hormones deficiency is recognized as one of the major etiological factors of male osteoporosis, in this case trabecular connectivity being seriously impaired [1] [2] [3] [4] . It is known that, with age, there appears a gradual decline in testosterone production and bone mineral density (BMD) [5] . Therefore, the reduced trophic role of androgens on muscle determines an increased risk for falling and the appearance of osteoporotic fractures [6] . The decrease of estradiol (E 2 ), derived from the conversion of testosterone under the influence of aromatase at target cells level (skin, fat, skeleton) brings about the reduction of antiresorptive effect and consequently the reduction of BMD [2, 7, 8] . Clinical and basic research demonstrates that E 2 is the main sex steroid required for bone homeostasis in men. The progressive decline of testosterone that usually occurs with advancing age might result in a corresponding decrease of circulating estrogens in men [9] . Both estradiol and testosterone are indispensable for the maintenance of bone health status in men [10] [11] [12] . Relative estrogen deficiency in elderly men with low testosterone is common and has been clearly demonstrated in most of the longitudinal studies on sex steroids in older men [9] .
In older men, 70-85% of the decrease in BMD related to sex steroids decline is imputable to estrogen deficiency, while only the remaining 15-30% is imputable to androgens. Data obtained from older men demonstrate that E 2 is inversely associated with BMD [13] and seems to predict fractures better than testosterone [14] .
Elderly males might present relative estrogen deficiency that may be involved in several age-related conditions [15] that can affect and worsen quality of life, including bone loss.
The role of sex steroids deficiency on bone turnover in men is inconclusive. Some studies support the hypothesis that low sex hormones levels are associated with reduced BMD [16] . In other researches, sex steroids levels were found not to be related to BMD and fracture risk [17, 18] .
To our knowledge, there have not been any studies on the effects of sex steroids on BMD in Romanian males. For this reason, our research aims at analyzing the role of sex steroids serum levels in evaluating osteoporosis in the men included in the study.
Materials and methods
This retrospective cross-sectional clinical study was conducted between 2008-2012 and enrolled 146 men who were diagnosed, by Dual-energy X-ray absorptiometry (DXA) method, with osteoporosis (T score ≤ -2.5 SD) or osteopenia (-2.5 SD < T score < -1 SD) (study group) and a control group that included 121 men with normal bone mineral density (T score ≥ -1SD). All subjects were evaluated after having given their informed consent. Patients' age ranged between 65 and 85 years old.
Inclusion criteria for the study group were the diagnosis of osteoporosis or osteopenia established by DXA method and for the control group, the normal values of BMD.
Exclusion criteria for both groups were neoplasia regardless of stage or location and psychiatric disorders that would affect cognitive ability and patients' compliance.
Patients' evaluation included: medical history and physical examination. The following anthropometric measurements were carried out: body mass and height to calculate the body mass index (BMI) expressed as body mass (kg) / square of body height (m 2 ). The measurements were performed in subjects without top clothing and shoes.
BMD was measured by a LUNAR DPX-NT densitometer (Medtel, Australia) in all patients included in the study. The DXA scans were obtained by standard procedures by the manufacturer for scanning and analysis. Patients' BMD was measured at the lumbar spine (anteroposterior projection at L1-L4) and at the femurs (i.e., femoral neck, trochanter, and total hip). The World Health Organization (WHO) classification system was applied, defining osteoporosis as T score ≤ -2.5 and osteopenia as -2.5 < T score < -1.
Blood for laboratory investigations was collected from the median cubital vein between 7.00 and 9.00 a.m. after overnight fasting (last meal on the preceding day at 6 p.m.) and the serum was stored until examinations at −20° C.
Hormonal investigations were carried out using a COBAS 6000 analyzer (Roche Diagnostics). Concentrations of total testosterone (Tt), free testosterone (Tf) were measured by the competitive immunochemical electrochemiluminescence method (ECLIA). E 2 serum concentration was measured by a competitive immunoenzymatic method (ELISA).
Sex steroid deficiency was considered: for Tt -below 2.25 ng/ml, for Tf -below 5.472 ng/L, and for E 2 -below 28 pmol/L.
Statistical analysis
The data were processed using International Business Machines -Statistical Package for the Social Sciences version 18.0, 2010 (IBM-SPSS 18.0, Armonk, New York, USA). The value of statistical significance was set at p < 0.05. The mathematical values of tests were declared for significant comparisons. For the parametric comparison, we used the t-test. For ordinal or non-parametric data, we used the Mann-Whitney test for comparing the two groups. Chi-square test was used in tables 2 * 2 with ordinal / nominal data. Multivariate analyses were performed using multiple logistic regression method, with the calculation of OR (CI95%).
Results
Upon analyzing the results, we found that the mean age of the patients included in the study was 72.9 ± 5.1 years. No significant differences were found between the two groups regarding BMI ( Table 1) .
The results revealed that mean lumbar BMD is significantly lower in the study group, when compared to the control group, U=8, z=-13.9, p<0.001, r=0.85, the size effect being very large. Mean hip BMD is also significantly lower in the study group in comparison to the control group, U=376.5, z=-13.5, p<0,001, r=0.82, the size effect being very large (Table 1) .
Men with decreased BMD were older, the mean age being significantly higher in study group compared to control group, t(265)=2.18, p=0.03 (Table 1) . However, if we compare the two groups depending on age groups, the difference is not significant. Also, when comparing the two groups according to the BMI categories, the difference is not statistically significant (Table 2).
No significant differences were found between the study group and the control group regarding mean Tt (3.98 ng/ml for the study group compared with 4.34 ng/ml for the control group; p=0.061). Tf levels were significantly lower in the study group when compared with the control group (6.56 ng/L vs. 7.65 ng/L, respectively), U=6207, z=-4.18, p<0.001, r=0.25, size effect being small to medium. Mean E 2 levels were significantly lower in the study group (38.53 pmol/L) compared to the control group (45.70 pmol/L), U=6942.5, z=-3.01, p=0.003, r=0.18, the size effect being small (Table 1) . These results demonstrate a significant association between reduced BMD and lower mean levels of Tf and E2 in men, but no association between low BMD and Tt.
Sex hormones deficiency (at least one sex steroid below normal level) was found in 45.21% of cases in patients with low BMD (from the study group) compared to a rate of 24.5% in the control group (p=0.001) ( Table 2) .
The distribution of patients on lower than normal and normal categories of Tt was not significantly different among groups (p=0.088; low value for 22 patients -15.1% from the study group compared with 10 patients -8.3% from the control group). Lower Tf levels were 1.95 times more frequent in the study group, when compared to the control group, χ 2 (1)=7.2, p=0.007 (low value for 82 patients -56.2% from the study group compared with 48 patients -39.7% from the control group). For the study group, OR was lower than the normal value of Tf (OR: 1.35; CI95%: 1.081 and 1.686) ( Table 2) .
Lower E 2 levels were 6.88 times more frequent in the study group in comparison to the control group, χ 2 (1)=7.2, p=0.007. Thus, 52 patients (35.6%) with altered parameter on DXA (study group) presented low E 2 compared with 9 patients (7.4%) of the control group. For the study group, OR was lower than the normal value of E 2 (OR: 1.86; CI95%: 1.557 and 2.241) ( Table 2 ). These results reflect that the Tf and E 2 deficiency were significantly correlated with low BMD.
Compared to the control group, the study group (with reduced BMD) had a higher number of patients with low serum levels of steroid sexual hormones, U=5855, z=-5.08, p<0.001 (Table 2). T score analysis in the study group revealed that 30.1% of men (44 cases) had osteopenia and 69.9% of patients (102 cases) presented osteoporosis. We found no differences between distribution of Tt categories among classes of osteopenia and osteoporosis. Significantly more cases with low Tf were found in the osteoporosis group compared to the osteopenia group, χ 2 (1)=5.95, p=0.015. For the osteoporosis class, OR was lower than normal value of Tf (OR: 1.31; CI95%: 1.041 and 1.659). Significant more cases of low levels of E 2 were found in the osteoporosis group, when compared with the osteopenia group, χ 2 (1)=19.32, p<0.001. For the osteoporosis class, OR was lower than normal value of E2 (OR: 1.61; CI95%: 1.32 and 1.95) ( Table 3 ). These results demonstrate that osteoporosis is positively correlated with Tf and E 2 deficiency. 
Discussions
Sex steroids deficiency represents, according to literature, a high incidence risk factor for osteoporosis in men [5, 7, 10, 11, 19, 20] . According to some authors, bone density, rate of bone loss and incidence of fractures are better correlated with serum estradiol level than with testosterone level [21, 22] . We observed a statistically significant correlation between sex hormones deficiency and the reduction of bone density (p=0.001), comparable with the results of other reports [4, 6, 23] .
We have demonstrated that BMD reduction is associated with sex steroids deficiency, in particular with decreased serum levels of Tf and E 2 . These results are consistent with other studies that have found a positive association between serum levels of Tf and BMD [16, [24] [25] [26] [27] . However, many researches [17, 28, 29] have shown a positive correlation between E 2 and BMD, whereas other authors [24, 26] reported the absence of this association. Another research showed that low levels of Tf and free estradiol and high levels of SHBG were associated with low BMD [30] .
No association between low BMD and Tt was found in our research. Regarding Tt, there are publications which revealed a lack of association with BMD [24, 26, 30] , however others [16, 31] proved that low levels of this hormone are accompanied with low BMD.
A study conducted on a sample of 976 men aged between 30 and 79 years showed that Tt and Tf serum levels did not correlate with BMD, instead total and free estradiol was strongly correlated with BMD especially in the total hip and femoral head [32] .
Our results showed that levels of Tf and E 2 were lower in men with reduced BMD compared to men with normal BMD. A prior study involved 2447 men aged over 65 years old and assessed the levels of Tt and total estradiol in those with low BMD compared to those with normal BMD.
The prevalence of osteoporosis was significantly higher in both men with Tt deficiency and those with low total estradiol [33] .
A research which included 609 men aged over 60 revealed that low testosterone is associated with increased risk of fracture, particularly with hip and non-vertebral ones [4] . These results suggest that the effect of testosterone on fracture risk in elderly men may be mediated by non-skeletal factors, such as muscle strength and/or risk of falling.
Our study has as limitation the lack of free estradiol and sex hormone binding globulin (SHBG) determination, which restricted the analysis of the role of these factors in the development of osteoporosis in men.
In conclusion, our study showed that sex steroids deficiency in our group of male patients is associated with bone loss. It can be stated that Tf and E 2 are more important than Tt in assessing the risk of osteoporosis in male subjects. Sex steroids measurement might be useful for identifying men at higher risk for osteoporosis.
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